Ducommun raises acquisition ambitions to $500m as defense growth accelerates

Ducommun Incorporated has unveiled an ambitious long-term growth strategy that could lift annual revenue to roughly $1.6 billion to $1.7 billion and adjusted EBITDA margin toward 23% by 2032, significantly expanding the aerospace and defense supplier’s acquisition and organic growth ambitions. The company remains on track to reach at least $950 million of revenue, an adjusted EBITDA margin of approximately 18% and engineered products representing around 25% of revenue under its existing VISION 2027 program. Its new VISION 2032 plan goes further by targeting larger acquisitions in the $300 million to $500 million range, a mid-teens compound annual growth rate across its core missile and radar franchise and continued expansion in commercial aerospace. Management also intends to increase engineered products to about 40% of revenue, a shift designed to strengthen pricing power and push margins materially above historical levels.

The strategy arrives after a substantial improvement in Ducommun’s financial and market position. Second-quarter revenue reached a record $224.5 million, up 12%, while adjusted EBITDA increased 21% to $38.4 million and adjusted EBITDA margin expanded to 17.1%. Remaining performance obligations reached an all-time high of approximately $1.16 billion, supported by $309.7 million of quarterly bookings and a book-to-bill ratio of 1.4 times. Ducommun’s market capitalization has also risen from roughly $605 million at the end of 2022 to around $2.6 billion, giving the company a stronger equity currency and greater capacity to pursue larger transactions.

VISION 2032 aims to take Ducommun from $950 million revenue toward a much larger aerospace and defense platform

Ducommun’s current VISION 2027 plan remains the bridge to the new strategy. Management says it is on track to meet or exceed all three major objectives established under that program: at least $950 million of annual revenue, an adjusted EBITDA margin around 18% and engineered products representing roughly one-quarter of revenue.

VISION 2032 then targets another major expansion. Management outlined revenue of approximately $1.6 billion to $1.7 billion by 2032 and another 500 basis points of adjusted EBITDA margin improvement after reaching the 2027 target, taking the long-term margin objective to roughly 23%. Engineered products are expected to increase from about 25% of revenue to approximately 40%.

That product-mix shift is central to the strategy because proprietary engineered products generally offer stronger differentiation and pricing power than conventional build-to-print manufacturing. Ducommun wants a larger portion of revenue tied to intellectual property, specialized engineering and products where replacing the supplier can be difficult because of certification, qualification and platform-specific requirements.

Management expects both acquisitions and internal investment to drive the increase. The 2032 plan includes approximately $250 million to $300 million of acquired engineered-product revenue, alongside continued organic expansion of the company’s existing proprietary portfolio.

Ducommun has already used acquisitions to expand into areas including magnetic seals, ammunition handling systems, lightning protection, thermoplastic extrusions and aerodynamic systems. Management argues those deals have helped move the business toward higher-value aerospace and defense content while contributing to the margin improvement already visible under VISION 2027.

The strategy therefore represents more than a revenue target. Ducommun is attempting to transform the economics of the company by combining higher-margin acquisitions, proprietary products and organic aerospace and defense growth so that earnings can grow faster than sales.

Missile and radar programs could become Ducommun’s fastest-growing franchise through 2032

Defense is expected to provide one of the strongest organic growth engines. Ducommun projects a mid-teens compound annual growth rate through 2032 across its core missile and radar franchise, which management believes could more than double over the planning period.

Recent operating results already show that defense programs are becoming more important. Military and space revenue totaled $123.8 million in the second quarter and $241.4 million during the first six months, compared with $115.9 million and $228.1 million respectively a year earlier.

Missile programs have been a particularly visible contributor. Ducommun recently received an award worth more than $35 million from Simmonds Precision Products to provide electronic assemblies supporting Lockheed Martin’s PAC-3 family of missiles. The contract builds on Ducommun’s existing PAC-3 business and will be supported from its Tulsa, Oklahoma engineering and manufacturing operation.

Management has also highlighted growth on the SM-6 missile platform and other defense programs, although quarterly results can vary depending on radar, naval, space and aircraft production schedules. The second quarter included solid military growth even as some radar, space and naval programs experienced temporary weakness.

Backlog provides additional visibility. Ducommun reported remaining performance obligations of approximately $1.16 billion, including roughly $722.7 million tied to military and space customers and $419.9 million to commercial aerospace. Management expects approximately 70% of total remaining performance obligations to convert into revenue within the following 12 months.

That does not make the backlog risk-free because defense programs can experience timing changes, budget adjustments and customer delays. It nevertheless gives Ducommun considerably more forward visibility than many smaller industrial suppliers and supports management’s confidence in continued growth.

Commercial aerospace recovery offers growth without the same capital demands as larger acquisitions

Commercial aerospace provides the second major organic pillar. Ducommun expects that business to grow at approximately a 6% to 7% compound annual rate through 2032, supported by higher production rates for aircraft including the Boeing 737 MAX, Boeing 787 and Airbus A320neo.

The recovery is already visible. Commercial aerospace revenue increased 16% in the second quarter to $89.4 million and reached $173.3 million during the first half, up from $148.8 million a year earlier. Management attributed the improvement largely to increasing narrowbody aircraft production.

One advantage of that growth is that Ducommun believes it can handle substantial additional commercial-aerospace volume without proportionally large capital investment. Existing facilities and capacity created during previous investment cycles should allow higher customer build rates to generate operating leverage as volumes increase.

That dynamic matters because VISION 2032 simultaneously calls for significantly more acquisition spending. A commercial aerospace recovery that can be captured with relatively modest incremental capital could help generate the cash needed to finance acquisitions and further engineered-product investment.

The risk is that aircraft production rates remain dependent on original equipment manufacturers and their supply chains. Any disruption involving aircraft certification, engine availability, labor, supplier capacity or production schedules can affect Ducommun even when long-term demand remains intact.

Diversification across commercial aircraft, missiles, radar, military aircraft and proprietary products therefore becomes increasingly important. Management’s strategy effectively combines cyclical aerospace recovery with longer-duration defense programs and acquisition-driven product expansion.

Larger acquisitions could accelerate growth but raise the execution bar for Ducommun

Perhaps the biggest change in VISION 2032 is the scale of Ducommun’s acquisition ambitions. Management is expanding its target range by approximately three to five times and now intends to consider transactions valued between $300 million and $500 million while continuing to pursue smaller bolt-on acquisitions.

That would represent a major step up for a company currently valued at roughly $2.6 billion. Larger acquisitions could add meaningful revenue and proprietary technology quickly, but they also introduce greater integration, financing and valuation risk than smaller transactions.

Ducommun enters the strategy from a stronger operating position. Second-quarter gross margin reached a record 28%, up 160 basis points, while net income increased 60% to $20.4 million and adjusted EBITDA margin reached 17.1%, already approaching the 18% VISION 2027 target.

Bookings also remain strong. Quarterly bookings of $309.7 million compared with $224.5 million of revenue produced a 1.4 times book-to-bill ratio, while first-half bookings reached $486.4 million against $433.5 million of revenue.

Those fundamentals give management more flexibility, but acquisition discipline will become increasingly important if transaction sizes rise toward $500 million. The market has already rewarded the company substantially, with total shareholder return of roughly 245% since the end of 2022 and the share price up about 81% during 2026 before the latest announcement.

Ducommun shares were trading higher following the updated strategy, adding to a strong longer-term run. The stock had closed around $172.50 immediately before the latest session, compared with a 52-week range of roughly $84.76 to $210.39.

That performance creates both opportunity and pressure. A stronger equity valuation can make stock-funded transactions more attractive, but investors will also expect future acquisitions to generate returns sufficient to support a valuation that has already expanded dramatically.

The VISION 2032 plan therefore raises the standard for execution. Ducommun has made substantial progress on margins, backlog and product mix under its current strategy, but moving toward $1.6 billion to $1.7 billion of revenue and a 23% adjusted EBITDA margin will require sustained defense growth, commercial aerospace execution and disciplined capital deployment over several years.

Key takeaways from Ducommun’s VISION 2032 aerospace and defense growth strategy

• Ducommun remains on track for at least $950 million of revenue and approximately 18% adjusted EBITDA margin under VISION 2027.
• VISION 2032 targets roughly $1.6 billion to $1.7 billion of annual revenue and adjusted EBITDA margin near 23%.
• Engineered products are expected to grow from around 25% of revenue in 2027 to approximately 40% by 2032.
• Ducommun plans to pursue larger acquisitions valued at roughly $300 million to $500 million alongside smaller bolt-on deals.
• The missile and radar franchise is targeted for a mid-teens compound annual growth rate through 2032.
• Commercial aerospace is expected to grow approximately 6% to 7% annually as Boeing and Airbus narrowbody production increases.
• Second-quarter revenue reached a record $224.5 million, up 12%, while adjusted EBITDA increased 21% to $38.4 million.
• Remaining performance obligations reached an all-time high of approximately $1.16 billion, including about $723 million from military and space programs.
• A recent PAC-3 missile-related award worth more than $35 million illustrates continued demand across Ducommun’s defense portfolio.
• Ducommun’s market capitalization has risen from roughly $605 million at the end of 2022 to about $2.6 billion, increasing its capacity to pursue larger strategic acquisitions.